One of them initiated coverage. The company has a very promising lead drug candidate.

Raymond James analyst Martin Auster initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Stro

Does Shattuck Labs, Inc. (STTK) have what it takes to be a top stock pick for momentum investors? Le

Geron (NASDAQ: GERN - Get Free Report) and Shattuck Labs (NASDAQ: STTK - Get Free Report) are both s

The consensus price target hints at an 85.3% upside potential for Shattuck Labs (STTK). While empiri

HC Wainwright & Co. analyst Joseph Pantginis maintains Shattuck Labs (NASDAQ:STTK) with a Buy

Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.12) per share which missed the analyst

He was encouraged by the progress of the company's SL-325. This, the biotech's lead drug candidate,

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Wall Street analysts changed outlook on top names. For full changes, upgrades, downgrades and initia

Markets took a brutal hit Thursday as oil prices, surging interest rates, and Middle East tensions s

JP Morgan analyst Brian Cheng initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Overweight

Leerink Partners analyst Faisal Khurshid initiates coverage on Shattuck Labs (NASDAQ:STTK) with a

Shattuck Labs, Inc. (NASDAQ: STTK - Get Free Report) has received an average recommendation of "Mode

U.S. stocks were mixed, with the Dow Jones gaining 100 points. Rezolve AI (RZLV) jumped 11.9%, and o

Shattuck Labs ($STTK) shares fluctuate after pricing a $75M public offering at $4.00/share. Get the

AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or

Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ:STTK), a clinical-stage bi

AUSTIN, Texas and DURHAM, N.C., June 09, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or

Citigroup analyst Yigal Nochomovitz maintains Shattuck Labs (NASDAQ:STTK) with a Buy and raises t

Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the

AUSTIN, Texas and DURHAM, N.C., June 09, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NA

Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline U

Shattuck Labs Inc. (NASDAQ:STTK) stock is down on Monday following news regarding its lead drug cand

Shattuck Labs' stock tumbles after Phase 1 SL-325 data release despite analyst upgrades, a Buy c

US stocks rose with Nasdaq up 400 points. Dow up 0.32%, Nasdaq up 1.55%, S&P 500 up 0.94%. Tech

Needham analyst Joseph Stringer maintains Shattuck Labs (NASDAQ:STTK) with a Buy and raises the p

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Bu

Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ:STTK), a clinical-stage biotechnology company

AUSTIN, TX and DURHAM, NC, June 08, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Co

Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the

AUSTIN, Texas and DURHAM, N.C., June 05, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NA

Citigroup analyst Yigal Nochomovitz upgrades Shattuck Labs (NASDAQ:STTK) from Neutral to Buy and

U.S. stocks trade lower on Friday, Nasdaq down 425 points. Merlin shares rise 35.93% after successfu

US stock futures higher, Nasdaq futures down. Concrete Pumping Holdings shares up 28.94% pre-market.

Wedbush analyst David Nierengarten maintains Shattuck Labs (NASDAQ:STTK) with a Outperform and ra

Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.13) per share which met the analyst con

AUSTIN, Texas and DURHAM, N.C., May 07, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or th

Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Shattuck Labs (NASDAQ:STTK) with

HC Wainwright & Co. analyst Joseph Pantginis maintains Shattuck Labs (NASDAQ:STTK) with a Buy

Aberdeen Group plc increased its stake in Shattuck Labs, Inc. (NASDAQ: STTK) by 462.1% during the fo

Shattuck Labs, Inc. (NASDAQ: STTK - Get Free Report) has earned a consensus recommendation of "Moder

Citigroup analyst Yigal Nochomovitz maintains Shattuck Labs (NASDAQ:STTK) with a Neutral and rais

The biotech published its final earnings report and business covering 2025. It posted a slightly nar

Wedbush analyst David Nierengarten maintains Shattuck Labs (NASDAQ:STTK) with a Outperform and ra

AUSTIN, Texas and DURHAM, N.C., March 05, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or